The Long Neglected Player: Modeling Tumor Uptake to Guide Optimal Dosing

Area of Science:

• Pharmacology
• Computational Biology
• Translational Medicine

Background:

• Pharmacokinetic (PK) modeling traditionally relies on drug exposure metrics.
• PK modeling is crucial for decision-making in translational medicine and patient care.

Purpose of the Study:

• To introduce a new paradigm in optimal dosing using mechanistic computational models.
• To integrate drug concentrations at the site of action within PK models.

Main Methods:

• Development of mechanistic computational models.
• Integration of existing knowledge into PK models.
• Focus on drug concentrations at the site of action.

Main Results:

• Mechanistic models offer a new approach to optimal dosing.
• Integration of site-of-action concentrations enhances PK modeling.
• Potential for improved decision-making in patient care.

Conclusions:

• Mechanistic computational models represent a paradigm shift in PK modeling.
• This approach can lead to more precise and effective dosing strategies.
• Enhanced PK modeling supports better translational medicine and patient outcomes.